Literature DB >> 24566169

Specific changes of gut commensal microbiota and TLRs during indomethacin-induced acute intestinal inflammation in rats.

Evangelina Terán-Ventura1, Mònica Aguilera2, Patri Vergara3, Vicente Martínez4.   

Abstract

BACKGROUND AND AIMS: Gut microbiota is a contributing factor in the development and maintenance of intestinal inflammation, although precise cause-effect relationships have not been established. We assessed spontaneous changes of gut commensal microbiota and toll-like receptors (TLRs)-mediated host-bacterial interactions in a model of indomethacin-induced acute enteritis in rats.
METHODS: Male Spague-Dawley rats, maintained under conventional conditions, were used. Enteritis was induced by systemic indomethacin administration. During the acute phase of inflammation, animals were euthanized and ileal and ceco-colonic changes evaluated. Inflammation was assessed through disease activity parameters (clinical signs, macroscopic/microscopic scores and tissue levels of inflammatory markers). Microbiota (ileal and ceco-colonic) was characterized using fluorescent in situ hybridization (FISH) and analysis of 16s rDNA polymorphism. Host-bacterial interactions were assessed evaluating the ratio of bacterial adherence to the intestinal wall (FISH) and expression of TLRs 2 and 4 (RT-PCR).
RESULTS: After indomethacin, disease activity parameters increased, suggesting an active inflammation. Total bacterial counts were similar in vehicle- or indomethacin-treated animals. However, during inflammation the relative composition of the microbiota was altered. This dysbiotic state was characterized by an increase in the counts of Bacteroides spp., Enterobacteriaceae (in ileum and cecum-colon) and Clostridium spp. (in ileum). Bacterial wall adherence significantly increased during inflammation. In animals with enteritis, TLR-2 and -4 were up-regulated both in the ileum and the ceco-colonic region.
CONCLUSIONS: Gut inflammation implies qualitative changes in GCM, with simultaneous alterations in host-bacterial interactions. These observations further support a potential role for gut microbiota in the pathophysiology of intestinal inflammation.
Copyright © 2014 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bacterial adherence; FISH; Gut commensal microbiota; Gut inflammation; Host–bacterial interactions; Inflammatory bowel disease; TLR; Toll-like receptors

Mesh:

Substances:

Year:  2014        PMID: 24566169     DOI: 10.1016/j.crohns.2014.02.001

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  16 in total

1.  Antibiotic-induced dysbiosis alters host-bacterial interactions and leads to colonic sensory and motor changes in mice.

Authors:  M Aguilera; M Cerdà-Cuéllar; V Martínez
Journal:  Gut Microbes       Date:  2015-01-20

2.  Substantial decreases in the number and diversity of microbiota during chemotherapy-induced gastrointestinal mucositis in a rat model.

Authors:  Margot Fijlstra; Mithila Ferdous; Anne M Koning; Edmond H H M Rings; Hermie J M Harmsen; Wim J E Tissing
Journal:  Support Care Cancer       Date:  2014-11-08       Impact factor: 3.603

3.  Cell-free probiotic supernatant (CFS) treatment alleviates indomethacin-induced enterocolopathy in BALB/c mice by down-modulating inflammatory response and oxidative stress: potential alternative targeted treatment.

Authors:  Arezki Samer; Ryma Toumi; Imene Soufli; Chafia Touil-Boukoffa
Journal:  Inflammopharmacology       Date:  2022-05-04       Impact factor: 5.093

Review 4.  Pain killers: the interplay between nonsteroidal anti-inflammatory drugs and Clostridioides difficile infection.

Authors:  Joshua Soto Ocaña; Nile U Bayard; Joseph P Zackular
Journal:  Curr Opin Microbiol       Date:  2021-12-08       Impact factor: 7.584

5.  Lipopolysaccharides facilitate colonic motor alterations associated to the sensitization to a luminal antigen in rats.

Authors:  Ferran Jardi; Monica Aguilera; Patri Vergara; Vicente Martinez
Journal:  J Neurogastroenterol Motil       Date:  2015-03-30       Impact factor: 4.924

6.  Gut Microbiota Mediates Protection Against Enteropathy Induced by Indomethacin.

Authors:  Xue Xiao; Geicho Nakatsu; Ye Jin; Sunny Wong; Jun Yu; James Y W Lau
Journal:  Sci Rep       Date:  2017-01-09       Impact factor: 4.379

7.  The Nonsteroidal Anti-Inflammatory Drug Ketorolac Alters the Small Intestinal Microbiota and Bile Acids Without Inducing Intestinal Damage or Delaying Peristalsis in the Rat.

Authors:  Barbara Hutka; Bernadette Lázár; András S Tóth; Bence Ágg; Szilvia B László; Nóra Makra; Balázs Ligeti; Bálint Scheich; Kornél Király; Mahmoud Al-Khrasani; Dóra Szabó; Péter Ferdinandy; Klára Gyires; Zoltán S Zádori
Journal:  Front Pharmacol       Date:  2021-06-04       Impact factor: 5.810

Review 8.  Gut Microbiota in NSAID Enteropathy: New Insights From Inside.

Authors:  Xianglu Wang; Qiang Tang; Huiqin Hou; Wanru Zhang; Mengfan Li; Danfeng Chen; Yu Gu; Bangmao Wang; Jingli Hou; Yangping Liu; Hailong Cao
Journal:  Front Cell Infect Microbiol       Date:  2021-07-06       Impact factor: 5.293

9.  Monocolonization of germ-free mice with Bacteroides fragilis protects against dextran sulfate sodium-induced acute colitis.

Authors:  Chien-Chao Chiu; Yung-Hao Ching; Yu-Chih Wang; Ju-Yun Liu; Yen-Peng Li; Yen-Te Huang; Hsiao-Li Chuang
Journal:  Biomed Res Int       Date:  2014-05-29       Impact factor: 3.411

10.  The distinct features of microbial 'dysbiosis' of Crohn's disease do not occur to the same extent in their unaffected, genetically-linked kindred.

Authors:  Umer Zeeshan Ijaz; Christopher Quince; Laura Hanske; Nick Loman; Szymon T Calus; Martin Bertz; Christine A Edwards; Daniel R Gaya; Richard Hansen; Paraic McGrogan; Richard K Russell; Konstantinos Gerasimidis
Journal:  PLoS One       Date:  2017-02-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.